nlyte Software Limited – Trademark Portfolio
Entity Type: 99
nlyte Software Limited holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include FIELDVIEW. The owner is based in London.
Riverside House
26 Osiers Road
London SW18 1NH , GB
Showing of trademarks Trademarks
Trademark Classifications
nlyte Software Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does nlyte Software Limited have?
nlyte Software Limited has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 2 cancelled.
What trademark classes does nlyte Software Limited file in?
nlyte Software Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are nlyte Software Limited's most well-known trademarks?
nlyte Software Limited's registered trademark portfolio includes well-known marks such as FIELDVIEW. These are among 1 currently registered trademark in the portfolio.
What is nlyte Software Limited's trademark registration success rate?
nlyte Software Limited has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.